U.S. Markets open in 2 hrs 24 mins
  • S&P Futures

    3,816.25
    -9.25 (-0.24%)
     
  • Dow Futures

    30,899.00
    -34.00 (-0.11%)
     
  • Nasdaq Futures

    11,635.25
    -39.00 (-0.33%)
     
  • Russell 2000 Futures

    1,733.50
    -4.80 (-0.28%)
     
  • Crude Oil

    112.59
    +0.83 (+0.74%)
     
  • Gold

    1,825.80
    +4.60 (+0.25%)
     
  • Silver

    20.92
    +0.05 (+0.23%)
     
  • EUR/USD

    1.0532
    +0.0007 (+0.0632%)
     
  • 10-Yr Bond

    3.2060
    0.0000 (0.00%)
     
  • Vix

    28.90
    +1.95 (+7.24%)
     
  • GBP/USD

    1.2161
    -0.0024 (-0.1946%)
     
  • USD/JPY

    136.5250
    +0.3970 (+0.2916%)
     
  • BTC-USD

    20,075.76
    -918.15 (-4.37%)
     
  • CMC Crypto 200

    434.30
    -15.77 (-3.50%)
     
  • FTSE 100

    7,286.07
    -37.34 (-0.51%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

The past year for Glaukos (NYSE:GKOS) investors has not been profitable

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Glaukos Corporation (NYSE:GKOS) shareholders should be happy to see the share price up 11% in the last month. But that doesn't change the fact that the returns over the last year have been less than pleasing. In fact the stock is down 47% in the last year, well below the market return.

It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.

Check out our latest analysis for Glaukos

Given that Glaukos didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

In the last twelve months, Glaukos increased its revenue by 24%. We think that is pretty nice growth. Unfortunately that wasn't good enough to stop the share price dropping 47%. You might even wonder if the share price was previously over-hyped. But if revenue keeps growing, then at a certain point the share price would likely follow.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

Glaukos is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So it makes a lot of sense to check out what analysts think Glaukos will earn in the future (free analyst consensus estimates)

A Different Perspective

While the broader market lost about 20% in the twelve months, Glaukos shareholders did even worse, losing 47%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 0.3% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 3 warning signs for Glaukos that you should be aware of.

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.